HIV infection is a chronic condition currently characterized by effective suppression of circulating virus under efficient antiretroviral therapy with the ...
Spybiotech Ltd. has filed a clinical trial application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate SPYVLP-01, a vaccine targeting human cytomegalovirus ...
Background: Cytomegalovirus (CMV) is the most common congenital infection in developed countries with reported incidences varying from 0.15% to 2.0%. Congenital CMV infection may be a cause of a ...
Maribavir is a benzimidazole riboside with activity against cytomegalovirus (CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in transplant recipients is not known.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results